{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 401952251
| Name = Chenodeoxycholic acid
| ImageFile = Chenodeoxycholic acid.png
| ImageSize = 260
| ImageAlt = Skeletal formula of chenodeoxycholic acid
| ImageFile1 = Chenodeoxycholic acid 3D ball.png
| ImageSize1 = 260
| ImageAlt1 = Ball-and-stick model of the chenodeoxycholic acid molecule
| IUPACName = chenodiol<br />OR<br />3α,7α-dihydroxy-5β-cholanic acid<br />OR<br />5β-cholanic acid-3α,7α-diol<br />OR<br />(''R'')-((3''R'',5''S'',7''R'',8''R'',9''S'',10''S'',13''R'',14''S'',17''R'')-3,7-dihydroxy-<wbr>10,13-dimethylhexadecahydro-<wbr>1''H''-cyclopenta[''a'']phenanthren-17-yl)pentanoic acid
|Section1={{Chembox Identifiers
| IUPHAR_ligand = 608
| UNII_Ref = {{fdacite|correct|FDA}}
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 240597
| UNII = 0GEI24LG0J
| InChI = 1/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1
| InChIKey = RUDATBOHQWOJDD-BSWAIDMHBF
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RUDATBOHQWOJDD-BSWAIDMHSA-N
| CASNo_Ref = {{cascite|correct|CAS}}
| CASNo = 474-25-9
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 9728
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB06777
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 16755
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = C02528
| SMILES = C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
}}
|Section2={{Chembox Properties
| Formula = C<sub>24</sub>H<sub>40</sub>O<sub>4</sub>
| MolarMass = 392.57 g/mol
| Density = 
| MeltingPtC = 165 to 167
| MeltingPt_notes = 
| BoilingPt = 
 }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = A05
| ATCCode_suffix = AA01
}}
}}
'''Chenodeoxycholic acid''' (also known as '''chenodesoxycholic acid''', '''chenocholic acid''' and '''3α,7α-dihydroxy-5β-cholan-24-oic acid''') is a [[bile acid]]. It occurs as a white crystalline substance insoluble in water but soluble in [[alcohol]] and [[acetic acid]], with melting point at 165–167&nbsp;°C. Salts of this [[carboxylic acid]] are called '''chenodeoxycholates'''. Chenodeoxycholic acid is one of the main bile acids produced by the [[liver]].<ref name="pmid12543708">{{cite journal |author=Russell DW |title=The enzymes, regulation, and genetics of bile acid synthesis |journal=Annu. Rev. Biochem. |volume=72 |issue= |pages=137–74 |year=2003 |pmid=12543708 |doi=10.1146/annurev.biochem.72.121801.161712 |url=http://arjournals.annualreviews.org/doi/full/10.1146/annurev.biochem.72.121801.161712?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed}}</ref>

It was first isolated from the bile of the domestic goose, which gives it the "cheno" portion of its name (Greek: χήν = goose).<ref>{{cite journal |author=Carey MC |title=Editorial: Cheno and urso: what the goose and the bear have in common |journal=N. Engl. J. Med. |volume=293 |issue=24 |pages=1255–7 |date=December 1975 |pmid=1186807 |doi= 10.1056/NEJM197512112932412|url=}}</ref>

Chenodeoxycholic acid and [[cholic acid]] are the two primary bile acids in humans. Some other mammals have [[muricholic acid]] or [[deoxycholic acid]] rather than chenodeoxycholic acid.<ref name="pmid12543708"/>

Chenodeoxycholic acid is synthesized in the liver from [[cholesterol]] by a process which involves several enzymatic steps.<ref name="pmid12543708"/>  Like other bile acids, it can be conjugated in the [[liver]] with [[taurine]] or [[glycine]], forming [[taurochenodeoxycholate]] or glycochenodeoxycholate. Conjugation results in a lower pKa. This means the conjugated bile acids are ionized at the usual pH in the intestine and will stay in the gastrointestinal tract until reaching the [[ileum]] where most will be reabsorbed. Bile acids form [[micelles]] which facilitate [[lipid digestion]]. After absorption, they are taken up by the liver and resecreted, so undergoing an [[enterohepatic circulation]]. Unabsorbed chenodeoxycholic acid can be metabolised by [[bacteria]] in the [[Colon (anatomy)|colon]] to form the secondary bile acid known as [[lithocholic acid]].

Choendeoxycholic acid is the most potent natural bile acid at stimulating the nuclear bile acid receptor, [[farnesoid X receptor]] (FXR).<ref name="pmid10334993">{{cite journal |vauthors=Parks DJ, Blanchard SG, Bledsoe RK |title=Bile acids: natural ligands for an orphan nuclear receptor |journal=Science |volume=284 |issue=5418 |pages=1365–8 |date=May 1999  |pmid=10334993 |doi= 10.1126/science.284.5418.1365|url=http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=10334993|display-authors=etal}}</ref> The transcription of many genes is activated by FXR.

==Therapeutic applications==
Chenodeoxycholic acid has been used as medical therapy to dissolve [[gallstone]]s.<ref name="pmid4580472">{{cite journal |vauthors=Thistle JL, Hofmann AF |title=Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones |journal=N. Engl. J. Med. |volume=289 |issue=13 |pages=655–9 |date=September 1973  |pmid=4580472 |doi=10.1056/NEJM197309272891303 |url=http://www.nejm.org/doi/abs/10.1056/NEJM197309272891303?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed}}</ref>

Chenodeoxycholic acid can be used in the treatment of [[cerebrotendineous xanthomatosis]].<ref name="pmid6504105">{{cite journal |vauthors=Berginer VM, Salen G, Shefer S |title=Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid |journal=N. Engl. J. Med. |volume=311 |issue=26 |pages=1649–52 |date=December 1984  |pmid=6504105 |doi=10.1056/NEJM198412273112601 |url=http://www.nejm.org/doi/abs/10.1056/NEJM198412273112601?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed}}</ref>

The Australian biotechnology company [[Giaconda (pharmaceutical company)|Giaconda]] has tested a treatment for [[Hepatitis C]] infection that combines chenodeoxycholic acid with [[bezafibrate]].<ref>{{cite web|last=Giaconda|title=Press release|url=http://www.fiercebiotech.com/press-releases/giaconda-suspends-hepaconda-phase-ii-trial-carry-out-dose-ranging|accessdate=5 April 2014}}</ref>

As [[diarrhea]] is a complication of chenodeoxycholic acid therapy, it has also been used to treat [[constipation]].<ref name="pmid6852359">{{cite journal |vauthors=Bazzoli F, Malavolti M, Petronelli A, Barbara L, Roda E |title=Treatment of constipation with chenodeoxycholic acid |journal=J. Int. Med. Res. |volume=11 |issue=2 |pages=120–3 |year=1983 |pmid=6852359 |doi= |url=}}</ref><ref name="pmid20691689">{{cite journal |vauthors=Rao AS, Wong BS, Camilleri M |title=Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis |journal=Gastroenterology |volume=139 |issue=5 |pages=1549–58, 1558.e1 |date=November 2010  |pmid=20691689 |pmc=3189402 |doi=10.1053/j.gastro.2010.07.052 |url=http://linkinghub.elsevier.com/retrieve/pii/S0016-5085(10)01147-9|display-authors=etal}}</ref>

In [[supramolecular chemistry]], [[molecular tweezers]] based on a chenodeoxycholic acid scaffold is a [[urea]] receptor that can contain [[Ion#Anions and cations|anions]] in its binding pocket in order of affinity: H<sub>2</sub>PO<sub>4</sub><sup>−</sup> (dihydrogen [[phosphate]]) > [[chlorine|Cl]]<sup>−</sup> > [[bromine|Br]]<sup>−</sup> > [[iodine|I]]<sup>−</sup> reflecting their [[base (chemistry)|basicities]] (tetrabutylammonium counter ion).<ref>Ki Soo Kim, Hong-Seok Kim ''Molecular Tweezer Based on Chenodeoxycholic Acid:Synthesis, Anion Binding Properties.'' Bulletin of the Korean Society 1411-1413 '''2004''' [http://newjournal.kcsnet.or.kr/main/j_search/j_bkcs_archives_view2.htm?code=B040927&qpage=j_bkcs&spage=j_bkcs_01 Article] {{webarchive |url=https://web.archive.org/web/20070927002925/http://newjournal.kcsnet.or.kr/main/j_search/j_bkcs_archives_view2.htm?code=B040927&qpage=j_bkcs&spage=j_bkcs_01 |date=September 27, 2007 }}</ref>
:[[Image:MolecularTweezerEmpl1.svg|450px|Molecular tweezer based on chenodeoxycholic acid]]

==See also==
*[[Ursodeoxycholic acid]] - an enantiomer
*[[Hyodeoxycholic acid]] - an isomer

==References==
{{Reflist}}

{{Bile and liver therapy}}
{{Nuclear receptor modulators}}

[[Category:Bile acids]]
[[Category:Alcohols]]
[[Category:Cholanes]]